Capital International Investors
EW icon

Capital International Investors’s Edwards Lifesciences EW Stock Holding History

Capital International Investors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,117,636
Closed -$140M – 460
2024
Q3 		$140M Buy
2,117,636
+14,747
+0.7% +$1.07M 0.03% 248
2024
Q2 		$194M Sell
2,102,889
-114,013
-5% -$10.1M 0.04% 221
2024
Q1 		$212M Sell
2,216,902
-6,824,658
-75% -$573M 0.04% 223
2023
Q4 		$690M Sell
9,041,560
-21,212,168
-70% -$1.48B 0.15% 131
2023
Q3 		$2.1B Buy
30,253,728
+3,238,696
+12% +$260M 0.53% 55
2023
Q2 		$2.55B Buy
27,015,032
+1,255,926
+5% +$109M 0.61% 43
2023
Q1 		$2.13B Buy
25,759,106
+3,017,120
+13% +$237M 0.55% 50
2022
Q4 		$1.7B Buy
22,741,986
+44,526
+0.2% +$3.43M 0.46% 65
2022
Q3 		$1.88B Buy
22,697,460
+293,568
+1% +$28.2M 0.55% 49
2022
Q2 		$2.13B Buy
22,403,892
+253,759
+1% +$26.3M 0.58% 44
2022
Q1 		$2.61B Buy
22,150,133
+218,908
+1% +$24.6M 0.59% 42
2021
Q4 		$2.84B Buy
21,931,225
+1,250,416
+6% +$146M 0.6% 40
2021
Q3 		$2.34B Buy
20,680,809
+677,929
+3% +$77.4M 0.54% 48
2021
Q2 		$2.07B Buy
20,002,880
+1,115,719
+6% +$105M 0.47% 54
2021
Q1 		$1.58B Buy
18,887,161
+1,037,653
+6% +$87.7M 0.4% 68
2020
Q4 		$1.63B Buy
17,849,508
+374,318
+2% +$31M 0.44% 56
2020
Q3 		$1.39B Buy
17,475,190
+1,215,774
+7% +$94.9M 0.43% 59
2020
Q2 		$1.12B Buy
16,259,416
+763,093
+5% +$54.2M 0.37% 68
2020
Q1 		$974M Buy
15,496,323
+2,122,371
+16% +$153M 0.4% 68
2019
Q4 		$1.04B Buy
13,373,952
+2,047,470
+18% +$160M 0.35% 87
2019
Q3 		$830M Buy
11,326,482
+2,917,980
+35% +$205M 0.32% 92
2019
Q2 		$518M Buy
+8,408,502
New +$508M 0.21% 115
2014
Q1 		– Sell
-5,100,000
Closed -$55.9M – 219
2013
Q4 		$55.9M Hold
5,100,000
– – 0.17% 146
2013
Q3 		$59.2M Sell
5,100,000
-1,272,000
-20% -$14.9M 0.25% 122
2013
Q2 		$71.4M Buy
+6,372,000
New +$75.4M 0.32% 104

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Capital International Investors's EW Position: Q4 2024 in Review

Capital International Investors sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 2,117,636 shares — an estimated $140M sold.

Capital International Investors first reported a position in EW in Q2 2013 and held it in 25 quarters. The position peaked at $2.84B in Q4 2021. 1,227 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Capital International Investors reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • Capital International Investors sold 2,117,636 Edwards Lifesciences shares in Q4 2024, an estimated $140M.
  • Capital International Investors first reported a position in Edwards Lifesciences in Q2 2013 and held it in 25 quarters.
  • Capital International Investors's Edwards Lifesciences position peaked at $2.84B in Q4 2021.
  • 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Capital International Investors's 13F filing for Q4 2024, filed 13 Feb 2025.